Advances & More News / Directly from the USA: Breakthrough SARS-CoV-2 Similar for Chronic Liver Disease With, Without Cirrhosis

Full vaccination cuts the risk for all-cause mortality for breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among chronic liver disease (CLD) patients with cirrhosis by two-thirds, according to a study published in the March issue of Hepatology. Jin Ge, M.D., from the University of California in San Francisco, and colleagues used data from the National COVID Cohort Collaborative to identify 278,457 CLD patients with or without cirrhosis who had SARS-CoV-2 testing. Source: Advances and More licensed by HealthDay

read more

For patients with non-small cell lung cancer (NSCLC), quitting smoking early is associated with lower mortality ... read more
Patients with systemic lupus erythematosus (SLE) have higher fetal and maternal morbidity in deliveries compared with ... read more
Incidence of Bell palsy is significantly more common following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ... read more
Genetically predicted rheumatoid arthritis (RA) is associated with osteoporosis, according to a study published online April ... read more